Log In

Forgot Password?
Create New Account

Loading... please wait

2024 Annual Meeting | C124 - Neurologic Complications of Checkpoint Inhibitors

Tuesday 04/16/24
01:00 PM - 03:00 PM MDT Add To Calendar
Colorado Convention Center | 702/704/706
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Jorg Dietrich, MD, PhD, FAAN
Neuro-oncology
Participants should gain an understanding of potential neurotoxic side effects of novel immunotherapies, including immune checkpoint inhibitors and CAR-T cells; learn to recognize clinical and imaging patterns of neurotoxicity after immunotherapy; and be able to discuss current management options and identify strategies designed to improve patient outcome.
2.00 CME credits
Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement
Intermediate
Neurohospitalist
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Case-based, Didactic, Audience Participation, Other

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:30 PM MDT Speaker Immunotherapy Associated Complications: Case Presentations from Clinical Practice
Amanda C. Guidon, MD
01:30 PM - 02:00 PM MDT Speaker Checkpoint Inhibitor-associated Peripheral Nervous System Complications
Leonie C. Muller-Jensen, MD
02:00 PM - 02:30 PM MDT Speaker Checkpoint Inhibitor-associated Central Nervous System Complications
James M. Hillis, MD
02:30 PM - 03:00 PM MDT Speaker CAR-T Cell Associated Neurologic Complications
Jorg Dietrich, MD, PhD, FAAN
Faculty Disclosures
Jorg Dietrich, MD, PhD, FAAN Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Dietrich has received publishing royalties from a publication relating to health care.
Amanda C. Guidon, MD An immediate family member of Dr. Guidon has received personal compensation for serving as an employee of GE Healthcare. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Momenta. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Guidon has received research support from MGFA. The institution of Dr. Guidon has received research support from Project Data Sphere. The institution of Dr. Guidon has received research support from MGNet. The institution of Dr. Guidon has received research support from MGNet. Dr. Guidon has received publishing royalties from a publication relating to health care.
Leonie C. Muller-Jensen, MD Dr. Muller-Jensen has nothing to disclose.
James M. Hillis, MD Dr. Hillis has stock in Elly Health. The institution of Dr. Hillis has received research support from GE Healthcare. The institution of Dr. Hillis has received research support from Annalise.ai. The institution of Dr. Hillis has received research support from Viz.ai. Dr. Hillis has received intellectual property interests from a discovery or technology relating to health care.